The outcomes showed that TSN could inhibit glioma progression property and induce apoptosis via upregulating the expression of miR-608 and downregulating the expression of miR-608 targets, Notch1 and Notch2, in glioma (Wang Q. et al., 2020). The gene discussed is TSN; the disease is central nervous system cancer.